ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sofinnova sells Breath Therapeutics to Zambon in $550m deal
July 29, 2019Venture capital firm Sofinnova Partners has dispossessed its portfolio company Breath Therapeutics to Italian pharmaceutical firm Zambon for a total consideration of up to $550m (€500m), including a €140m upfront payment. -
Charity LifeArc sells rights to Keytruda for more than $1bn
May 22, 2019UK-based medical research charity LifeArc has sold its royalty interest in Merck’s Keytruda (pembrolizumab) for $1.297bn to the European subsidiary of Canada Pension Plan Investment Board (CPPIB). -
AstraZeneca Sells Infant Drug Rights for $1.5B
November 14, 2018AstraZeneca Sells Infant Drug Rights for $1.5B
Pharma Sources Insight January 2025
